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ABSTRACT
Although CD4 T cells can have an important role in mediating lethal graft-versus-host disease (GVHD)
directed to multiple minor histocompatibility antigens (miHA) after bone marrow transplantation, their precise
characterization and effector function remains elusive. In this regard, T cell receptor (TCR) V spectratype
analysis has been a powerful tool for identifying donor CD4 T cell populations expanding to host miHA after
bone marrow transplantation in the major histocompatibility complex–matched C57BL/6 (B6) ¡ C.B10-H2b
(BALB.B) model of lethal GVHD. Removal of all of the V T cell families containing these responding cells
from the donor inoculum has proven to be an effective means of preventing the development of GVHD.
Previous studies have also found that of the 11 miHA-responsive B6 CD4 V T cell families, transplantation
of V2 and V11 T cells together into lethally irradiated BALB.B mice appeared to be primarily responsible
for the severity of resultant GVHD. Further focusing on these critical CD4 responses, in this study we
demonstrate that B6 CD4V11 T cells alone can induce lethal GVHD in BALB.B recipients. In addition,
immunohistochemical staining of host lingual and intestinal epithelial tissues supported the capacity of V11
T cells to infiltrate typical GVHD-associated target areas. To further characterize the specific CD4V11 T
cells involved in this anti-miHA response, TCR V spectratype analysis was performed and indicated that 6 V
chains were used by this reactive population. These results provide further evidence that a restricted repertoire
of T cell specificities, presumably recognizing a correspondingly low number of miHA, is sufficient for the
induction of severe GVHD.
© 2006 American Society for Blood and Marrow Transplantation
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iNTRODUCTION
The wide diversity of the T cell repertoire is
chieved by both rearranging gene segments compos-
ng each T cell receptor (TCR)  and  chain and
ombining these 2 chains to form the ﬁnal het-
rodimer structure. During a T cell response, the
epertoire can become signiﬁcantly skewed as a result
f the signiﬁcant clonal and/or oligoclonal expansion
f antigen-speciﬁc T cells [1-3]. This same repertoire m
18kewing can also be observed in the context of allo-
eactive responses, as in the case of the development
f graft-versus-host disease (GVHD) after allogeneic
lood and marrow transplantation [4-7].
GVHD is mediated by T cells from the donor
ematopoietic stem cell inoculum and is often char-
cterized by immunopathological injury to the skin,
ntestinal tract, and liver, leading to morbidity and
ortality [8]. Although it is well accepted that remov-
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V Repertoire in miHA Response 819ng donor T cells from the graft can signiﬁcantly
ecrease the incidence and severity of GVHD, the
ack of a functioning T cell repertoire in the recipient
esults in increased leukemic relapse, engraftment fail-
re, and opportunistic infections [9]. An alternative
pproach is to identify and remove only those speciﬁc
cells primarily involved in the alloreactive antihost
esponse associated with GVHD, thus preserving a
arge part of the T cell repertoire to provide the
eneﬁcial T cell–associated effects. In this regard, we
ave previously used TCRV CDR3-size spectratype
nalysis to characterize the skewing of the T cell
epertoire in response to minor histocompatibility an-
igens (miHA) in the B6 ¡ BALB.B H2b-matched
train combination [10-12]. Using the information
btained from this analysis to manipulate the donor
noculum by depleting the alloreactive V families,
e found improved survival rates for the transplantation
ecipients [5,10-12]. Similarly, in the haploidentical B6
(B6xDBA2)F1 strain combination, spectratype analy-
is was also used to identify leukemia-reactive V T
ells, which when transplanted into lethally irradiated
umor-challenged mice could mediate an effective graft-
ersus-leukemia response without GVHD development
4,5,10,13,14].
An appreciation for the role of the TCR chain in
erms of antigen recognition is evolving. Several stud-
es using single  or  chain transgenic mice indicated
hat most responding T cells could use various 
hains but only 1  chain [15-18]. These murine
tudies, indicating a contributing role of the TCR
hain in antigen recognition, were further supported by
nalysis of lesions in autoimmune- and GVHD-associ-
ted patients [6,17,19,20]. In addition, crystal structure
nalysis of a TCR interacting with a peptide–major his-
ocompatibility complex (MHC) II complex revealed
hat the  chain actually made more peptide contacts
han the  chain [21]. Other studies showed a require-
ent for conservation within both  and  chains when
utations within the J regions could eliminate T cell
esponses to peptide [22]. Taken together, these results
uggested that the TCR chain may play a more signif-
cant role in antigen recognition than was originally
hought. Consequently, we hypothesized that analysis of
speciﬁc CD4 T cell response against miHA during
he development of GVHD would reveal preferential
 chain usage.
To investigate the breadth of TCR chain diver-
ity, we again used the B6 ¡ BALB.B strain combi-
ation and focused on 1 of the 2 CD4V T cell
opulations that were previously observed to be di-
ectly involved in the severity of the disease [4]. Spec-
ratype analysis indicated that B6 CD4 V2 and
11 T cells were skewed in the antihost response,
nd that transplantation of an enriched population of
oth of these cells into lethally irradiated BALB.B
ecipients resulted in the development of lethal PVHD, whereas the transplantation of the remaining
2 and V11 T cells did not [12]. Consequently,
n the current study, we sought to demonstrate the
apacity of B6 CD4 V11 T cells on their own to
nduce GVHD, as well as to examine the complexity
f this response by TCR V spectratype analysis. The
esults indicated that B6 CD4 V11 T cells could
e found inﬁltrating both lingual and intestinal sites of
arly immunopathological injury associated with
VHD. Furthermore, these reactive T cells used only
V chains, further demonstrating that an allogeneic
esponse of limited scope can be of profound conse-
uence in the development of GVHD.
ATERIALS AND METHODS
ice
C57BL/6By (B6; H2b) and C.B10/LiMcdJ
BALB.B; H2b) mice were purchased from the Jack-
on Laboratory (Bar Harbor, ME). In addition,
ALB.B mice were provided from our own breed-
ng colony. Male mice, age 6-12 weeks, were always
sed as donors; both female and male mice, age 8-12
eeks, were used as recipients. Mice were housed in
pathogen-free environment in autoclaved mi-
roisolator cages and were provided with autoclaved
ood and water ad libitum. The treatment of the
nimals was approved by the Institutional Animal
are and Use Committees of both Thomas Jeffer-
on University and Hackensack University Medical
enter.
solation of CD4 T Cells and GVHD Induction
BALB.B splenocytes (2  107) were injected in-
raperitoneally into B6 donor mice 17-21 days before
VHD induction. Spleens and lymph nodes (LNs)
ere collected from the presensitized B6 mice, resus-
ended in Gey’s balanced salt solution, containing
.7% NH4Cl, to eliminate erythrocytes from the sus-
ension, and washed with phosphate- buffered saline
PBS; BioWhittaker, Walkerville, MI) containing
.1% bovine serum albumin (BSA; Sigma, St. Louis,
O). B cells were then depleted from the spleen and
N cells by a panning procedure with plate-bound
oat anti-mouse IgG (1:200 dilution; Cappel-Or-
anon, Teknika, West Chester, PA) for 1 hour at 4°C.
dherent cells were washed and resuspended in PBS
ontaining 0.1% BSA (PBS/BSA) along with rat IgM
nti-CD8 monoclonal antibody (mAb; 1:100 dilution
f supernatants from hybridoma cells grown in Cel-
ine ﬂasks, clone 3.168; BD PharMingen, San Diego,
A [23]) and guinea pig complement (1:6 dilution;
ockland, Boyertown, PA) for 45 minutes at 37°C to
eplete CD8 T cells. Bone marrow cells were ob-
ained from primed B6 mice by ﬂushing femurs with
BS/BSA, and T cell–depleted bone marrow cells
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C. G. DiRienzo et al.820ATBM) were prepared by incubation with anti Thy-1
Ab (J1j [24]; 1:100 dilution of supernatant) and com-
lement for 45 minutes at 37°C.
For induction of GVHD, 2  106 ATBM cells
long with 1.7-2.0  107 enriched CD4 T cells were
njected intravenously (i.v.) (0.25 mL of PBS) into
ethally irradiated (9.5 Gy single dose or 13 Gy split
ose) BALB.B recipients, using a Mark I model 68A
esium source (JL Shephard, San Fernando, CA).
ome V11 transfer experiments were also performed
t Hackensack University Medical Center, using a
ammacell 40 exactor (MDS Nordion, Ottawa, On-
ario, Canada) with an exposure of 8.5 Gy. For V11
ransfer experiments, presensitized B6 CD4 T cells
ere enriched as described above, and positively se-
ected V11 cells (96%–99% purity) and the remain-
ng V11 cells were sorted by magnetic cell separa-
ion using the VarioMACS system (Miltenyi Biotech,
uburn, CA). The number of V11 cells were in-
ected at its percent equivalent of the total unseparated
D4 population. These cell populations along with
TBM (2  106) were injected i.v. into lethally irra-
iated (8.5-10 Gy) BALB.B recipients.
DNA Isolation/Spectratype Analysis
Ten days following transplantation of 2  107
ALB.B-presensitized B6 CD4 T cells (without
TBM cells) into irradiated (9.5 Gy) BALB.B mice,
pleen and LN cells were harvested, enriched for
D4 T cells, and V11 cells selected magnetically
97%–99% purity, determined by ﬂow cytometric
nalysis), as described earlier. Ultraspec (Biotecx Lab-
ratories, Houston, TX) was added to the selected
ells, and RNA was extracted according to the manu-
acturer’s instructions and as described previously
10,25]. RNA was precipitated in isopropanol; the
ellet was dissolved in diethyl pyrocarbonate water,
eated for 10 minutes at 56°C, then combined with
Nasin (40 U/L), Moloney murine leukemia virus
M-MLV) reverse-transcriptase (RT) buffer, oligo
dT)s (20 mmol/L), deoxynucleoside triphosphates
20 mmol/L), and M-MLV RT (300 U/uL) for 1.5
ours at 37°C. Reagents for cDNA synthesis were
btained from Promega (Madison, WI), and the oligo
dT)s were synthesized in the Kimmel Cancer Center
ligo Synthesis Facility. RNA integrity was veriﬁed
ith -actin primers.
olymerase Chain Reaction Amplification of
DNA for V CDR3-Size Spectratyping
A ﬂuorescent-labeled C constant primer (PE-
pplied Biosystems, Foster City, CA) was used to
mplify the 3= end of cDNA, and primers speciﬁc for
ach of the V families were used to amplify the 5=
nd of the cDNA. Constant primers and primers for
 families 1-13 have been published previously [26]. Phe National Center for Biotechnology Information
ucleotide database was used to search for sequences
sed to generate primers for V 13-22. A BLAST search
f these primers revealed that they did not overlap with
ther non-TCR sequences. The following primers
ere used for V 13-22: V13, TGAGGCCGAGTT-
AGGAAGA;V14,GAGTCCTCAG-TCCCTGGT-
G, V15, AACGATTCTCCCTGCACATC; V16,
TGTAGTGCAGAG-CCCTTCC; V17, TTC-
ATCGGACTCATCATCA;V18,AGAAGCGCA-
TGGA-AGACTC; V19, TGCCTCATACCT-
TGTGCTG; V20, TTCTCACTGCACATCAC-
GC; and V22, GGAAAGGGTCTCCACTTTG.
Polymerase chain reaction (PCR) was performed
sing the reagents and methods described previously for
CR V CDR3-size spectratype analysis [5,10]. Brieﬂy,
DNA was added to a mixture of MgCl2 (25 mmol/L),
eoxynucleoside triphophates (800 M), 10  Taq
olymerase buffer B (Promega), V sense primer (20
mol/L), Ca antisense primer (12 mol/L), and Taq
olymerase (1 U/L), in a volume of 50 L. After 35
ycles of PCR, seminested PCR was performed as de-
cribed earlier using 20% of the ﬁrst-round product, the
roduct’s respective V sense primer (20 mol/L), and
he ﬂuorescent-labeled Cb antisense primer (12 mol/
). After another 35 cycles of ampliﬁcation, products
ere run on a sequencing gel.
uantitation of CDR3 Size Usage
V spectratype analyses were performed 3 sepa-
ate times for both control B6 and experimental
ALB.B CD4 V11 T cells to obtain statistical
igniﬁcance and reproducibility of results. After PCR
roducts were run on a sequencing gel, they were
nalyzed as described previously [5] using the Geno-
yper Genescan software program (PE-Applied Bio-
ystems), which depicts each PCR product as a histo-
ram. Histogram peaks were labeled 1-6, with 1
ssigned to the smallest peak and 6 assigned to the
argest peak. The average area under each experimen-
al peak for each V family was compared with the
verage area under the corresponding peak in the B6
ontrol mice. The experimental peak was considered
kewed when the mean area under the peak exceeded
he mean plus 3 times the standard deviation of the
ame B6 control histogram peak.
istologic Staining and Immunohistochemistry
Techniques for immunohistochemistry of frozen
ections were described previously [27,28]. Brieﬂy,
urine tongue and distal ileum were removed, em-
edded in OCT compound (Miles Laboratories,
lkhart, IN), and snap-frozen in liquid nitrogen. Sec-
ions (5 m) were cut on a cryostat, air-dried, and then
cetone-ﬁxed at 20°C. Sections were blocked with
BS containing 5% BSA and 0.1% Tween-20 (PBS-
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V Repertoire in miHA Response 821SA/Tween), then incubated for 1 hour with primary
Ab, either ﬂuorescein isothiocyanate–murine–anti-
5 or rat–anti-V11 (both at 1:50 in PBS-BSA/
ween; Pharmingen). Secondary antibodies were bi-
tinylated goat anti–ﬂuorescein isothiocyanate and
iotinylated goat anti-rat IgG, respectively (1:200 in
BS-BSA/Tween; Vector Laboratories, Burlingame,
A), and were incubated for 30 minutes at 20°C. A
ertiary antibody of horseradish peroxidase–conju-
ated anti-goat Ig was then added and developed with
he NovaRed substrate kit SK-4800 (Vector Labora-
ories). Slides were counterstained with Mayer’s he-
atoxylin solution for contrast.
ESULTS
VHD Potential of CD4 V11 T Cells in
ALB.B Recipients
A previous study of the GVHD-associated B6 anti-
ALB.B CD4 TCR V repertoire found that al-
igure 1. GVHD potential of V11-enriched B6 CD4 T cells. (A)
 106 B6 ATBM cells alone or in combination with either 2  1
3.7% double-positive B6 T cells. (B) Survival of transplanted recip
f initial body weight. Data are from a single experiment, representa
D4 T cells (n  3) or CD4V11 T cells (n  5) versus B6 ATBMhough V skewing was indicative of alloreactive ex-
ansion, it did not always correlate with the potential
or those particular V cells to mediate severe GVHD
24]. In this case, the combined transfer of detectably
kewed B6 CD4 V10 and V12 T cells into irra-
iated BALB.B recipients did not result in severe
VHD, whereas combined transfer of V2 and
11T cells was a very potent mediator of disease. To
ore precisely examine the repertoire diversity of the
CR V chain during the development of GVHD, we
ought to ﬁrst determine the extent of B6 CD4
11 T cell involvement during this response when
ransferred alone into BALB.B recipients. BALB.B-
resensitized B6 CD4 V11 T cells were enriched
Figure 1(A)] by magnetic cell sorting using anti-V11
Ab, as described previously [4] and transferred
5.6  105 cells/mouse) i.v. into lethally irradiated
ALB.B recipients along with 2  106 ATBM cells.
ontrol mice received 2  106 ATBM cells, either
lone or along with 2 107 unfractionated B6 CD4
B mice were lethally irradiated (13 Gy, split dose) and injected with
ractionated B6 CD4 T cells or 5.6  105 CD4V11 enriched
) Body weights for each group normalized as the mean percentage
the 3 experiments performed. BALB.B receiving unfractionated B6BALB.
07 unf
ients. (C
tive of(n  3); P  .001.
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C. G. DiRienzo et al.822cells. The results indicated that both unfractionated
D4 and CD4 V11 T cells alone were able to
ediate lethal GVHD, whereas the recipients receiv-
ng no T cells exhibited 100% survival [P  .001;
igure 1(B)]. Analysis of recipient body weight also
ndicated equivalent signiﬁcant weight loss in the 2 T
ell groups throughout the course of the 80-day ex-
eriment [Figure 1(C)].
6 CD4 V11 T Cells Infiltrate BALB.B Target
rgans During GVHD
The skin and intestinal tract are 2 major target
rgans affected during the immunopathological devel-
pment of GVHD. In human skin, alloreactive T cell
nﬁltration is concentrated around the epidermal rete
idges located at the interface of the dermis and epi-
ermal layers [29]. Although murine skin does not
xhibit rete ridge structures, the counterpart to human
kin can be found in the rete-like prominences of the
orsal tongue squamous epithelium, a site also tar-
igure 2. Immunohistochemical identiﬁcation of B6 V11 T ce
rradiated (8.5 Gy) BALB.B recipients, 9 days after transplantation
nfractionated B6 CD4 T cells (B), 7  105 B6 CD4V11 T c
f cells that stained with the anti-V11 mAb procedure, which was
ells, with apposition of effector cells primarily evident at this time
epresentative of each group (n  3), and from a total of 3 similar experimeted by T cells mediating GVHD [29,30]. We have
reviously used in situ analysis of lingual epidermal
njury to conﬁrm the presence of several spectratype-
kewed B6 V families in GVHD development in
ALB.B mice, mediated by CD4 T cells at day 30
osttransplantation [5]. Here we investigated whether
D4 V11 T cells could inﬁltrate murine rete-like
rominences and crypts of the small intestine in the
bsence of CD4 T cells from other V family mem-
ers. Immunohistochemical analysis of lingual epithe-
ium demonstrated that transfer of either unfraction-
ted B6 CD4 or CD4 V11 T cells into lethally
rradiated BALB.B recipients resulted in lymphocyte
nﬁltration within the superﬁcial submucosa and epi-
helium of both dorsal lingual tissue [Figures 2(B)
nd (C), respectively] and intestinal crypts 9 days after
ransplantation [Figures 3(B) and (C), respectively],
ompared with recipients receiving either ATBM
(Figures 2(A) and 3(A)] or V11-depleted CD4 T
ells [Figures 2(D) and 3(D)]. Peak pathology was
rating BALB.B lingual epithelium. Lingual epithelium of lethally
ither 2  106 B6 ATBM cells, alone (A), or along with 1.8  107
, or 7  105 B6 CD4V11 T cells (D). Arrows denote examples
nt only in recipients receiving unfractionated CD4 or V11 T
to the dermis and basal layers. Tissues were from a single mouse,lls inﬁlt
with e
ells (C)
appare
pointents.
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V Repertoire in miHA Response 823bserved on day 15 in both the lingual epithelium and
he small intestine, as reﬂected by the number of
poptotic cells within these given tissues (Figure 4).
he total number of T cells, including the V11 T
ell population, seemed to be declining in the
ongue by day 15, although it was still increasing
n the intestinal crypts by that time point. The
umber of apoptotic cells in a syngeneic B6 ¡ B6
ontrol group (lethally irradiated B6 mice trans-
lanted with B6 ATBM and 2.0  107 enriched
D4 T cells) was  0.1/mm for lingual tissues and
0.1/crypt for intestinal tissues, and the number of
onreactive (ie, not skewed in the spectratype anal-
sis) V5 T cells inﬁltrating those same tissues was
egligible at both time points (data not shown).
hese data supported the capacity of B6 CD4
11 T cells to inﬁltrate at least 2 major BALB.B
VHD-associated target tissues in the absence of
ther V families, consistent with their ability to
ediate lethal disease.
6 CD4V11 T Cells Combine with
ll TCR V Chains
Given the likelihood that the TCR uses both of its
igure 3. Immunohistochemical identiﬁcation of B6 V11 T cells
nﬁltrating BALB.B crypts of the small intestine. Crypts of lethally
rradiated (8.5 Gy) BALB.B recipients 9 days after transplantation
ith either 2  106 B6 ATBM cells alone (A) or along with 1.8 
07 unfractionated B6 CD4 T cells (B), 7  105 B6 CD4V11
cells (C), or 7  105 B6 CD4V11 T cells (D). Arrows denote
xamples of cells that stained with the anti-V11 mAb procedure,
hich was apparent only in recipients receiving unfractionated
D4 or V11 T cells. Inﬁltration and architectural disruption of
rypt epithelium are evident and cells in the lamina propria are also
f note. Tissues were from a single mouse, representative of each
roup (n  3), and from a total of 3 similar experiments.and  chains during donor T cell recognition of (ecipient miHA, we next investigated the scope of
CR chain usage by the B6 CD4 V11 T cells
ssociated with the GVHD response. Certain TCR
 chains have been shown to have a preference for
ecognition of either MHC class I or MHC class II
olecules [31]. Similarly, certain TCR V chains
ave also been reported to exhibit a preference for
igure 4. Apoptotic injury in lingual and intestinal tissue. BALB.B
ice were irradiated (8.5 Gy) and injected i.v. with 2  106 B6
TBM cells along with 7  105 B6 CD4V11 T cells. Analysis
f relative apoptotic injury (black bars) and V11 T-cell inﬁltra-
ion (white bars) was performed at days 10 and 15 on tissue samples
f tongue and small intestine. In the tongue, the number of apo-
totic cells per linear mm in rete ridge-like prominences signiﬁ-
antly increased by day 15, whereas the total number of T cells,
ncluding the V11 T cells, in the entire epithelium was already
iminishing by this time point. In the small intestine, both the
umber of apoptotic cells and inﬁltrating V11 T cells per crypt
ere elevated by day 15. Apoptotic cells were enumerated using
onventional light microscopy, based on the criteria of nuclear
ondensation and/or fragmentation and cytoplasmic hypereosino-
hilia. V11 T cells were enumerated through standard cell
ounting methods for immunohistochemical preparations. Where
easible, at least 20 linear mm of lingual epithelium and 50 crypts
ere evaluated per animal (n  5) and the mean values expressed
SEM  10%).
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C. G. DiRienzo et al.824ombining with certain TCR V chains as well [32].
o determine whether there was any preexisting TCR
 bias for combining with V11, we enriched B6
ymphocytes for CD4 V11 T cells by magnetic
orting and used similar methodology as for the TCR
 chain spectratyping to amplify each of the 21 TCR
 families from this population. The resulting his-
ograms for each of the V11-associated TCR V
amilies were complex and unskewed, exhibiting a
aussian distribution of CDR3 size (Figure 5), dem-
nstrating that there was no inherent bias for a par-
icular rearranged V chain to combine with the
11 chain.
imited TCR V Chain Involvement During
he GVHD Response
To determine whether there would be restricted
CR chain usage by B6 CD4 V11 T cells in
esponse to stimulation by miHA during the develop-
ent of GVHD, we ﬁrst transplanted 2  107
ALB.B-presensitized unfractionated B6 CD4 T
ells i.v. into lethally irradiated BALB.B mice. Ten
ays later, spleens and LNs were harvested from
ALB.B recipients, and CD4 V11 T cells were
ositively selected by magnetic cell separation (98%
urity). TCR V spectratype analysis was performed,
nd the CDR3-size distribution for 20 resolvable V
amilies was examined and compared with that of
ontrol spectratypes from normal B6 CD4 V11 T
ells. The results, summarized in Figure 6, indicate
igniﬁcant skewing (P  .05) in 6 of the 20 tested V
amilies. V9, 13, 14, and 18 exhibited skewing in 1
eak; V6 and 22, in 2 peaks. These data indicate that
igure 5. TCR V histograms from a population of normal B6
D4V11 T cells. B6 CD4 T cells were prepared from a pool
f lymphocytes from 20 B6 mice and were positively selected by
agnetic cell separation based on cell surface expression of V11.
NA was extracted from V11-enriched cells, and RT-PCR was
erformed using 22 TCR V-speciﬁc primers. Histograms are
hown for each of the TCR V families ampliﬁed and are repre-
entative results from 3 separate experiments.limited number of TCR V chains combine with the eopulation of B6 CD4 V11 T cells responding to
ALB.B miHAs in the context of a GVHD response.
ISCUSSION
We initially observed that puriﬁed CD4 T cells
ere able to mediate severe lethal GVHD in the B6¡
ALB.B strain combination, and that this response
ould be due to a limited number of reactive speciﬁc-
ties [4,33]. Subsequent studies, using TCR V spec-
ratype analysis to examine the scope of this response
hrough biased CDR3-size skewing, suggested that
he V2 and 11 families might play a dominant role in
otentiating disease [5,11,12]. This notion was sup-
orted by the observation that V11 T cells exhib-
ted a 2-fold increase in inﬁltration of the lingual
pithelium of BALB.B recipients transplanted with B6
D4 T cells. In addition, V2 and 11 were both
onsistently skewed in the spleen at days 7, 11, 15, 33,
nd 40 posttransplantation throughout the course of
he GVHD response [11]. The important role of these
ells was further conﬁrmed by experiments in which
6 CD4 V2- and V11-enriched T cells were
o-transplanted into lethally irradiated BALB.B recip-
ents, where they elicited severe GVHD. Further-
ore, excluding these 2 V families from the donor
D4 T cell inoculum resulted in signiﬁcantly re-
uced GVHD and increased survival [12].
It was not clear, however, whether either of these
V families could mediate GVHD when transferred
ndividually into recipients. It could be argued that
nﬁltration of 1 of the CD4 V T-cell types into a
articular tissue may be required to cause a threshold
mount of tissue destruction, generating cryptic
pitopes that would then be recognized by the other
 T cell, resulting in signiﬁcant target tissue dam-
ge [34]. Alternatively, biased usage of a V chain
ound in the peripheral lymphoid system, indicative of
response to miHA, does not always correlate with
he ability of that same V family member to mediate
mmunopathology in all target tissues [35]. This may
esult from those T cells’ inability to gain access to
articular tissue sites due to either the absence of
peciﬁc adhesion molecules or the lack of tissue-spe-
iﬁc miHA expression [36-39]. The current study ex-
ends our previous results by demonstrating that
ransplanted B6 CD4 V11 T cells alone can cause
VHD-associated weight loss and mortality. In addi-
ion, immunohistochemical analysis demonstrated
hat these cells can inﬁltrate both lingual and intesti-
al epithelium in BALB.B recipients, suggesting ap-
ropriate expression of the targeted miHA in both
arget tissues.
Because antigen recognition may involve both the
and  TCR chains, we sought to investigate thextent to which B6 CD4 V11–associated V was
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V Repertoire in miHA Response 825estricted in the response to miHAs. Using CDR3-
ize spectratype analysis, we found that 6 TCR V
amilies (V 6, 9, 13, 14, 18, and 22) were skewed
ithin the V11T-cell response obtained during the
evelopment of GVHD in BALB.B recipients. This
iased TCR V usage suggests recognition of a lim-
ted number of targeted BALB.B miHAs during this
11 response. It is also interesting to note that
pectratype histograms for the V16 and V19 fami-
ies could not be resolved in the anti-miHA B6 CD4
11 T cell population. The failure to generate
hese PCR products is not likely due to the inability of
hese particular V’s to combine with the V11
rotein, because both V16 and V19 histograms
ere successfully generated for normal CD4 V11
cells. Rather, it is possible that the V16 and V19
amilies may somehow be deleted in vivo from the
igure 6. TCR V histograms from a population of B6 anti-BALB
cells were injected IV into lethally irradiated BALB.B mice. Ten
D4V11 T cells were positively selected by magnetic cell sepa
erformed using 22 TCR V-speciﬁc primers. Histograms are show
esults from 3 separate experiments.esponding B6 CD4 V11 T cell population. TData reported previously from our laboratory sup-
ort the hypothesis that a limited number of BALB.B
iHAs are being targeted during the B6 CD4 T cell
esponse, as evidenced by interrecombinant inbred
train GVHD analysis and V spectratype analysis of
he responding B6 T cells [5,11,32]. Here we have
xtended the characterization of the miHA-reactive
6 CD4 V:11 T cells through analysis of the
CR V chain and have conﬁrmed the restricted
sage by these T cells, thereby implying that there
nly a single miH, or at most a few miHA, may be
esponsible for eliciting this severe immunopatholog-
cal response. The relevance of this ﬁnding is that
dentifying these important miHA might allow us to
ocus on similar types of antigens in the clinical setting
o avoid the development of severe GVHD. Further
ocus on the combinational diversity of TCR V with
4V11 T cells. BALB.B-presensitized unfractionated B6 CD4
ater, spleens and LN were harvested from BALB.B recipients, and
RNA was extracted from V11-enriched cells, and RT-PCR was
ch of the skewed TCR V families ampliﬁed and are representative.B CD
days l
ration.
n for eaCR V, along with varying TCR expression patterns
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C. G. DiRienzo et al.826ithin sites of tissue damage, will contribute to our
nderstanding of GVHD directed against miHAs.
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